Active cytomegalovirus retinitis after the start of antiretroviral therapy.
Where this comes from
- Record sourced from PubMed, PMID 30196272.
- Also identified by DOI 10.1136/bjophthalmol-2018-312406 and PMC identifier 9982650.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Patients with AIDS-related cytomegalovirus (CMV) retinitis receiving combined antiretroviral therapy (cART), but not specific anti-CMV therapy, consistently showed active retinitis for several months. Delayed diagnosis and treatment of CMV retinitis may have severe consequences. Patients first entering care with advanced HIV infection and vulnerability to reactivation of latent CMV infection should be screened immediately for CMV retinitis by dilated indirect ophthalmoscopy and treated with specific anti-CMV therapy without delay, in addition to cART.
Medical subject headings
- AIDS-Related Opportunistic Infections
- Antiviral Agents
- Cytomegalovirus Retinitis